1,3-oxathiolane nucleoside compounds and compositions
US5538975A · kind A · utility
53Cited by
9References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 1994 |
| Grant date | Jul 23, 1996 |
| Priority date | — |
| Expiry date | Feb 1, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P41/006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 1,3-oxathiolane nucleoside analogues and their use in the treatment of viral infections. More specifically, this invention relates to (-)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidi n-2-one and pharmaceutically acceptable derivatives and pharmaceutical formulations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.